您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

RNA干扰靶向沉默HER2/neu基因对卵巢癌细胞株SK-OV3的影响

衣翠华,侯明,李丽珍,张昕,魏军民,黎莉,郝静   

  1. 山东大学齐鲁医院肿瘤防治研究中心, 山东 济南 250012
  • 收稿日期:2006-03-29 修回日期:1900-01-01 出版日期:2006-10-24 发布日期:2006-10-24
  • 通讯作者: 衣翠华

Effects of RNAi on HER2/neu gene and proliferation of SKOV3 ovarian cancer cells in vitro

YI Cui-hua, HOU Ming, LI Li-zhen,ZHANG Xin,WEI Jun-min,LI Li, HAO Jing   

  • Received:2006-03-29 Revised:1900-01-01 Online:2006-10-24 Published:2006-10-24
  • Contact: YI Cui-hua

摘要: 目的:观察siRNA表达质粒稳定转染靶向沉默HER2/neu基因对SKOV3卵巢癌细胞株的影响。方法:针对HER2/neu基因序列构建短发夹状siRNA真核表达载体(pGenesil1HER2/neu),转染卵巢癌细胞株SKOV3,G418筛选出稳定转染株后,采用RTPCR和Western Blot法观察HER2/neu基因的沉默效果;CCK8比色分析检测细胞体外增殖活力;流式细胞仪检测细胞周期。结果:测序证实成功构建HER2/neu的2个短发夹状siRNA真核表达质粒;稳定转染SKOV3细胞后,转染了特异性HER2/neu siRNA的细胞HER2/neu mRNA及p185蛋白水平均明显低于亲本细胞及转染无义对照序列的细胞;CCK8比色分析显示HER2/neu基因沉默的细胞存活分数明显低于HER2/neu基因高表达的细胞(P=0.000);流式细胞仪细胞周期分析也显示,HER2/neu基因沉默的细胞处于凋亡状态及非增殖期的比例明显增加(P均<0.01),而处于合成期的比例却显著减少(P≤0.001)。结论:靶向HER2/neu基因的短发夹状siRNA可从转录及翻译水平有效地沉默HER2/neu基因;HER2/neu基因沉默的SKOV3卵巢癌细胞增殖明显受抑制。

关键词: 基因疗法 , HER2/neu基因, 卵巢癌, RNA干扰

Abstract: To investigate the effects of HER2/neu gene silencing on SKOV3 ovarian cancer cells by RNA interference. Methods: Design and synthesize two siRNAs based on the sequence of HER2/neu mRNA. They were separately subcloned into the plasmid of pGenesil1 containing U6 promoter. The pGenesil1 vectors of the RNA interference eukaryotic expression specific to HER2/neu gene were constructed. The pGenesil1 vectors were transfected into SKOV3 ovarian cancer cells with METAFECTENE in vitro. The positive cell clones were obtained after being screened with 250?μg/ml G418. Then the effects of RNAi on the expression of HER2/neu gene were detected by RTPCR and Western Blot. The cellular growth activities were assayed by CCK8 colorimetry and flow cytometry in vitro. Results: DNA sequencing of the plasmids verified the successful construction of the HER2/neu siRNA vectors. Compared with the blank and the control group, the expressions of HER2/neu mRNA and protein 185 were remarkably downregulated in the RNAi groups; and the cell proliferations decreased in the RNAi groups. Conclusion: We successfully construct the recombinant plasmids of siRNAs specific to HER2/neu gene and transfect them into the SKOV3 ovarian cancer cells in vitro. The RNAi inhibits the expression of HER2/neu mRNA and protein 185, and subsequently suppresses the proliferation of SKOV3 cells.

Key words: RNA interference, HER2/neu gene, Ovarian cancer cell, Gene therapy

[1] 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2] 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[3] 袁宗怀,潘广晔,迟曰梅,安传国,张永刚. 孟德尔随机化分析低级别浆液性卵巢癌与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2025, 63(1): 99-107.
[4] 何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.
[5] 焦光丽,石子馨,陈蓉,宋亚博,杨飞,崔书君. 基于增强CT影像组学预测卵巢癌患者铂类药物敏感性[J]. 山东大学学报 (医学版), 2023, 61(12): 62-69.
[6] 张艺馨,赵玉立,封丽. 超声特征及术前CA-125联合对51例卵巢交界性及Ⅰ期恶性肿瘤的鉴别诊断[J]. 山东大学学报 (医学版), 2022, 60(7): 104-109.
[7] 哈春芳,李茹月. 卵巢癌耐药机制与靶向治疗策略的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 117-123.
[8] 陈君宇, 曹冬焱. 以脑梗为首发的卵巢癌病例报告[J]. 山东大学学报 (医学版), 2021, 59(5): 110-112.
[9] 张小红,周云,杜秋莹,任慧欣,王超群. Atg7-siRNA通过调节精氨酸循环干扰食管癌ECA109细胞放疗敏感性[J]. 山东大学学报 (医学版), 2021, 59(4): 28-34.
[10] 王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 25-31.
[11] 王宝金,赵欣欣,李霞,马倩,王新月,孙阳,史中娜. miR-203靶向Survivin抑制卵巢癌细胞增殖、迁移与侵袭[J]. 山东大学学报 (医学版), 2020, 58(12): 23-28.
[12] 刘崇东,娄彤,董靖. 子宫内膜异位症恶变[J]. 山东大学学报 (医学版), 2019, 57(6): 27-32.
[13] 关红卫,李娟,孙锐,刘婕,李长忠. 乌苯美司对卵巢癌A2780细胞的生物学影响[J]. 山东大学学报 (医学版), 2019, 57(12): 46-51.
[14] 朱爱国,马振敕,王健. 利用上皮源性卵巢癌预后的多基因信息建立预测预后模型[J]. 山东大学学报 (医学版), 2019, 57(10): 80-85.
[15] 杨佳欣,沈铿,王遥. 妇科恶性肿瘤保留生育功能治疗的现状与展望[J]. 山东大学学报 (医学版), 2018, 56(5): 1-7.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!